 |
The Riuniti hospital in Bergamo is working on a system for the new Pope John XXIII hospital that provides for the administration of medicines in single doses and which will make it possible to respond in a more targeted and personalized way to the needs of individual patients, supplying them only with the precise quantity of medicine they need, without waste. The project was presented in Milan by the general manager of the Bergamo hospital, Charles Nicora during a meeting for the presentation of a survey on the purchasing processes of medical devices.
"Our choice - explains Nicora - was to make an investment to guarantee zero waste and a reduction in expenses in the near future, redesigning the management process for drugs and soon also for medical devices. In Bergamo, for example, all together they weigh over 100 million euros on the hospital coffers, over 57 million drugs, 33.5 million medical devices, plus 12 million for diagnostics".
In particular, explains the general manager, in the new way of dispensing medicines “a third-party company is involved which unpacks and repackages the therapies in a single-dose version. The products are then placed inside 4 robotic cabinets which, like snack dispensers, dispense therapies for each patient based on what is prescribed by the doctors”. In this way, there will no longer be open, half-consumed and thrown away packets of medicines, and the impact of errors should also be reduced, thanks to the barcode labels that uniquely link the medicine to the patient"
The process begins with the tender (lasting 9 years) for the assignment of the support service to the hospital pharmacy for the computerized management of the single-dose drug and for the management of medical devices and prostheses. "Tender that is being held for three hospitals - the Hospital of Riuniti Hospitals of Bergamo, the Hospital of Cremona Institutes and the Hospital of the Province of Pavia - and is worth a total of 65 million euros. At the end of these 9 years, savings of more than 10% are expected".
The tender model adopted envisages the contractor's remuneration with the 'fee' system, disbursing the price in two phases: the 50% regardless and the 50% upon obtaining the result.
The project will start in 2012, "in the first 3 months of next year, tests will begin in 4 departments identified for measuring the benefits. At the end of the year, however, we expect to bring precise data on the activity", announces Nicora.
http://www.pharmastar.it/index.html?cat=7&id=6914 5 December 2011
